Erzurum Technical University Sport Sciences Faculty
Erzurum, 25240, Turkey (Türkiye)
NCT Number: NCT07181057
Objectives: The purpose of this study is to examine how meal timing in a one-meal-a-day (OMAD) regimen influences neurocognitive outcomes.
Methods: Twelve cognitively active participants (academics, students, software engineers) will complete three randomized OMAD conditions, consuming a standardized isocaloric meal at 08:00, 12:30, or 18:00. ERPs will be recorded during a computerized Stroop task to evaluate peak amplitudes and latencies under congruent and incongruent conditions. Resting-state EEG will be measured under eyes-open and eyes-closed conditions. Behavioral performance on the Stroop task, including reaction time and accuracy, will also be assessed.
Looking for future studies?
Notify Me20 year–40 year
Male
Interventional
Not applicable
Erzurum, 25240, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Male, 20 to 45 years of age
Right-handed
Normal or corrected-to-normal vision
Cognitively active individuals (academic staff, graduate students, or software/algorithm engineers)
Regular sleep-wake schedule during the week preceding the experiment
Ability to abstain from caffeine, alcohol, or psychoactive substances for at least 24 hours prior to each test session
Body mass index between 18.5 and 30 kg/m²
Exclusion criteria
History of neurological, psychiatric, metabolic, or sleep disorders
Current use of medications that affect the central nervous system
Shift work or irregular sleep patterns (verified by sleep diary)
Prior experience with one-meal-a-day dietary routines
Body mass index below 18.5 or above 30 kg/m²
Arm Title: Morning Meal (08:00)
Intervention: Other: One-meal-a-day (OMAD)
Description: Participants consume a single isocaloric meal at 08:00.
Arm Title: Midday Meal (12:30)
Intervention: Other: One-meal-a-day (OMAD)
Description: Participants consume a single isocaloric meal at 12:30.
Arm Title: Evening Meal (18:00)
Intervention: Other: One-meal-a-day (OMAD)
Description: Participants consume a single isocaloric meal at 18:00.
Time frame: Day 1 Morning session (09:30-11:00, pre-meal) and Day 1 Afternoon session (14:30-16:00, ~6 hours post-meal). Each participant completes three separate test days (morning, midday, evening feeding), ≥48 hours apart.
Maximum voltage deflection (µV) within 250-450 ms after stimulus onset at CP1, CP2, Pz, P3, O1, and O2 electrodes, recorded during congruent Stroop trials using a 32-channel EEG system.
Time frame: Day 1 Morning session (09:30-11:00, pre-meal) and Day 1 Afternoon session (14:30-16:00, ~6 hours post-meal). Each participant completes three separate test days (morning, midday, evening feeding), ≥48 hours apart.
Time point (ms) of maximum positive deflection within 250-450 ms after stimulus onset at CP1, CP2, Pz, P3, O1, and O2 electrodes.
Time frame: Day 1 Morning session (09:30-11:00, pre-meal) and Day 1 Afternoon session (14:30-16:00, ~6 hours post-meal). Each participant completes three separate test days (morning, midday, evening feeding), ≥48 hours apart.
Broadband spectral power (µV²) recorded at CP1, CP2, Pz, P3, O1, and O2 electrodes during standardized eyes-open and eyes-closed resting-state EEG.
Erzurum Technical University
Other
Synergistic Effects of Green Tea Extract and Ginger Supplementation on Endurance Performance and Thermal Perception in Normal and Cold Environments: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Acronym: OMAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01557439
Fasting State
Ahmedabad, Gujarat, India
View Trial DetailsNCT01577914
Fasting State
Ahmedabad, Gujarat, India
View Trial DetailsNCT01618799
Fasting State
Ahmedabad, Gujarat, India
View Trial DetailsNCT01603173
Fasting State
Ahmedabad, Gujarat, India
View Trial Details